(Q48518666)

English

Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

author name string

Yoko Tanaka

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Takeshi Sassa

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Eiji Yoshitome

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Yoshiyuki Asai

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Hiroo Ikehira

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Tetsuya Suhara

7

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Yoshiro Okubo

8

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Toru Nishikawa

9

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Psychiatry and Clinical Neurosciences

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

60

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

365-372

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

In vivo 1H MRS choline: correlation with in vitro chemistry/histology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

The profiles of clinical deterioration in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Wisconsin Card Sorting Test deficits in chronic paranoid schizophrenia. Evidence for a relatively discrete subgroup?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Perseveration in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

A multimethod approach to assessing perseverations in schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Neural damage due to temporal lobe epilepsy: dual-nuclei (proton and phosphorus) magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Basal ganglia N-acetylaspartate correlates with the performance in the procedural task 'Tower of Hanoi' of neuroleptic-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Decreased left frontal lobe N-acetylaspartate in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Selective Relationship Between PrefrontalN-Acetylaspartate Measures and Negative Symptoms in Schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2006.01515.X

21 January 2018

Identifiers

10.1111/J.1440-1819.2006.01515.X

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/16732755

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48518666&oldid=2200984951"